Results 201 to 210 of about 388,090 (360)

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

Small Methods, EarlyView.
The review presents a comprehensive overview of each component of lipid nanoparticles（LNPs）and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu, Nei Li, Yudian Xiao, Rohan Palanki, Hannah Yamagata, Michael J. Mitchell, Xuexiang Han   +6 more
wiley   +1 more source

In Vitro Modification of Human Immunodeficiency Virus Type 1 (HIV‐1) Infectivity by the U937 Cells [PDF]

, 1993
Mohamed A. El‐Farrash, Takao Masuda, Marcelo J. Kuroda, Shinji Harada   +3 more
openalex   +1 more source

Frequency and Genotype Diversity of Human Pegiviruses (HPgV) in People Infected with Human Immunodeficiency Virus (HIV). [PDF]

Infect Dis Clin Microbiol
Yücebağ-Duranay E, Kocazeybek BS, Kuşkucu MA.   +2 more
europepmc   +1 more source

Rapid and Sensitive Detection of RNA Viruses through Imaging of Marker Molecules Derived from Designed Circular DNA Probes

Small Methods, EarlyView.
This study presents a rapid and sensitive virus detection method that employs imaging of virus‐specific DNA markers. Utilizing specially designed single‐stranded circular DNA probes, this method captures RNA fragments from RNase‐digested viral genomes during the reverse transcriptase‐based reaction, resulting in double‐stranded markers that are ...
Yoon‐ha Jang, Taesoo Kim, Su‐jin Hong, Se‐yeon Kim, Hyeseung Hwang, Siwon Kim, Su‐a Kang, Nabin Won, Dogeun Kim, Min Jae Kim, Yong Pil Chong, Seongsoo Jang, Kyubong Jo, Kwang‐il Lim   +13 more
wiley   +1 more source

The use of AZT in asymptomatic patients infected with the human immunodeficiency virus (HIV) negatively affects their quality of life [PDF]

, 1994

openalex   +1 more source

Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Leishmaniasis (LI) is a vector‐borne illness caused by a protozoan of the genus Leishmania. Data on the features of LI in patients with inflammatory bowel disease (IBD) are scarce. Aim To describe the characteristics of patients with IBD who present with leishmaniasis, infection outcomes and the risk factors associated with ...
L Madero‐Velázquez, A Mínguez, L Mayorga, JJ Ramírez, N Moreno, C Amorós, MA Nieto, R Mena, JM Benítez, L Gimeno‐Pitarch, N Maroto, C Suria, F Rodríguez‐Moranta, I Ordás, L Ruiz, MA García‐Brenes, A Martín‐Cardona, C Rubín de Célix, K Cárdenas, D Ginard, L Medina, N Pedrero, R Plaza, R Salmoral, TJ Martínez‐Pérez, V Algara, E Merino, Y Zabana, A Gutiérrez, on behalf of Young Group of GETECCU   +29 more
wiley   +1 more source

Syngeneic adoptive transfer of anti-human immunodeficiency virus (HIV- 1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin [PDF]

, 1994
FRANÇOISE BEX, Philippe Hermans, S Sprecher, A Achour, R Badjou, C Desgranges, J Cogniaux, P Franchioli, C Vanhulle, A Lachgar   +9 more
openalex   +1 more source

Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Weight loss is an effective therapeutic strategy for patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). This study aimed to identify factors that predict relevant weight loss, defined as at least 7% of initial body weight, in MASLD outpatients.
Nicola Pugliese, Ivan Arcari, Federica Cerini, Rosa Lombardi, Federica Turati, Grazia Pennisi, Matteo Soleri, Simone Rocchetto, Diletta De Deo, Michele Sagasta, Chiara Masetti, Anna Ludovica Fracanzani, Salvatore Petta, Carlo La Vecchia, Mauro Viganò, Alessio Aghemo   +15 more
wiley   +1 more source

IMPLEMENTATION OF HEALTH SERVICES FOR PRISONERS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN CLASS IIA PURWOKERTO CORRECTIONAL INSTITUTION

Journal of Management Small and Medium Enterprises (SME's)
This study aims to determine the implementation of health services for the fulfillment of human immunodeficiency virus (HIV) sufferers in Class IIA Purwokerto Correctional Institution.
Mico Jeje Saputra, Vivi Sylviani Biafri
doaj  

The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis. [PDF]

PLoS One
Zhang M, Huang Y, Zhang S, Peng S.
europepmc   +1 more source